The ultimate goal in the Clinical Research space is to make trials more accessible to the broader population. Inevitably, the industry has been struggling with enrollment and recruitment.
In this episode, our guest
Darcy Forman, Chief Delivery Officer at
Science 37, shares insight into the implications of increasing clinical research accessibility, from increasing awareness among the general population to testing medications within the populations that will ultimately benefit from the treatments.
Join us as we discuss:
- Pros and cons of transitioning from the pharmaceutical industry to the tech vendor/business side
- Pressing challenges of enrollment and recruitment in clinical trials
- Hurdles to providing global scalable execution
The Next Phase: Exploring Innovation in Clinical Trials